IP Library › Assignment 076014/0635
Patent Assignment
Reel/Frame 076014/0635

Assignment of Assignor's Interest

Recorded: 2026-07-20 Pages: 30
Assignor
EAGLE PHARMACEUTICALS, INC.
Executed: 2026-06-18
Assignee
COSETTE PHARMACEUTICALS, INC.
200 CROSSING BOULEVARD, BRIDGEWATER, NEW JERSEY, 08807
Covered Properties (47)
Treatment using dantrolene
Application: 60/451,249 →
Prophylaxis and treatment of malignant hyperthermia and other disorders using low volume colloidal suspensions of dantrolene
Application: 60/539,324 →
Treatment Using Dantrolene
Application: 17/064,693 →
Publication: US US20210015796A1
Dantrolene Formulations and Methods Of Their Use
Application: 62/674,394 →
Dantrolene Formulations and Methods of Their Use
Application: 17/052,572 →
Publication: US US20210236467A1
Methods Of Using Dantrolene To Treat Nerve Agent Exposure
Application: 62/554,049 →
Methods Of Using Dantrolene To Treat Nerve Agent Exposure
Application: 62/674,406 →
Methods of Using Dantrolene to Treat Nerve Agent Exposure
Application: 16/644,281 →
Publication: US US20200383954A1
Methods of Using Dantrolene to Treat Nerve Agent Exposure
Application: 17/540,878 →
Publication: US US20220087980A1
Dantrolene Prodrugs and Methods of Their Use
Application: 62/575,124 →
Dantrolene Prodrugs and Methods Of Their Use
Application: 62/674,422 →
Dantrolene Prodrugs and Methods of Their Use
Application: 18/918,855 →
Publication: US US20250145593A1
Use of Dantrolene And Dantrolene Prodrugs To Treat Radiation Exposure
Application: 62/772,001 →
Methods of Treating SARS-CoV-2 Infections
Application: 63/008,486 →
Methods of Treating SARS-COV-2 Infections
Application: 63/062,599 →
Methods of Treating Severe Acute Respiratory Syndrome
Application: 63/008,529 →
Methods of Treating Severe Acute Respiratory Syndrome
Application: 63/062,623 →
Methods of Treating Coronavirus Infections
Application: 63/008,547 →
Methods of Treating Coronavirus Infections
Application: 63/062,608 →
Methods of Treating Coronavirus Infections
Application: 17/995,606 →
Publication: US US20230143775A1
Methods of Treating Viral Infections
Application: 63/008,561 →
Methods of Treating Viral Infections
Application: 63/062,615 →
Methods of Treating Viral Infections
Application: 17/995,608 →
Publication: US US20230149364A1
Treatment Using Dantrolene
Patent: 7,758,890 →
Application: 10/788,413 →
Publication: US US20040242646A1
Treatment Using Dantrolene
Patent: 8,110,225 →
Application: 12/717,588 →
Publication: US US20100160400A1
Treatment Using Dantrolene
Patent: 8,685,460 →
Application: 13/353,478 →
Publication: US US20120121662A1
Treatment Using Dantrolene
Patent: 8,604,072 →
Application: 13/353,480 →
Publication: US US20120121663A1
Treatment Using Dantrolene
Patent: 9,271,964 →
Application: 14/103,546 →
Publication: US US20140099382A1
Treatment Using Dantrolene
Patent: 9,603,840 →
Application: 14/950,571 →
Publication: US US20160074366A1
Treatment Using Dantrolene
Patent: 9,789,090 →
Application: 15/144,124 →
Publication: US US20160243083A1
Treatment Using Dantrolene
Patent: 9,884,044 →
Application: 15/406,237 →
Publication: US US20170143677A1
Treatment Using Dantrolene
Application: 15/865,404 →
Publication: US US20180125822A1
Treatment Using Dantrolene
Application: 16/397,176 →
Publication: US US20190255021A1
Dantrolene Prodrugs and Methods of Their Use
Application: 16/755,255 →
Publication: US US20200239455A1
Dantrolene Prodrugs and Methods of Their Use
Application: 17/751,806 →
Publication: US US20220324850A1
Use of Dantrolene and Dantrolene Prodrugs to Treat Radiation Exposure
Application: 17/295,522 →
Publication: US US20220023319A1
Methods of Treating Sars-Cov-2 Infections
Application: 17/995,602 →
Publication: US US20230144719A1
Methods of Treating Severe Acute Respiratory Syndrome
Application: 17/995,604 →
Publication: US US20230149363A1
Methods of Treating Viral Infections
Methods of Treating Coronavirus Infections
Methods of Treating Severe Acute Respiratory Syndrome
Methods of Treating Sars-Cov-2 Infections
Use of Dantrolene and Dantrolene Prodrugs to Treat Radiation Exposure
Dantrolene Prodrugs and Methods of Their Use
Methods of Using Dantrolene to Treat Nerve Agent Exposure
Dantrolene Formulations and Methods of Their Use
Treatment Using Dantrolene
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Jun 15, 2004
From: ANDERSON, DAVID M.; CAMERANSI, JR. BENJAMIN G.; CONKLIN, VINCENT M.
To: LYOTRIPIC THERAPEUTICS, INC.
Reel/Frame 015461/0192 →
Corrective Assignment to Correct the Name of the Assignee Previously Recorded on Reel 015461 Frame 0192. Assignor(S) Hereby Confirms the Name of the Assignee Is Lyotropic Therapeutics, Inc.. May 26, 2010
From: ANDERSON, DAVID M.; CAMERANSI, BENJAMIN G., JR.; CONKLIN, VINCENT M.
To: LYOTROPIC THERAPEUTICS, INC.
Reel/Frame 024459/0398 →
Assignment of Assignor's Interest Nov 2, 2017
From: HEPNER, ADRIAN
To: EAGLE PHARMACEUTICALS, INC.
Reel/Frame 044018/0433 →
Assignment of Assignor's Interest Mar 1, 2018
From: WESCOTT, CHARLES
To: EAGLE PHARMACEUTICALS, INC.
Reel/Frame 045078/0167 →
Assignment of Assignor's Interest Aug 13, 2018
From: HEPNER, ADRIAN
To: EAGLE PHARMACEUTICALS, INC.
Reel/Frame 046626/0705 →
Assignment of Assignor's Interest Aug 22, 2018
From: WESCOTT, CHARLES; HEPNER, ADRIAN
To: EAGLE PHARMACEUTICALS, INC.
Reel/Frame 046661/0232 →
Assignment of Assignor's Interest Aug 30, 2018
From: WESCOTT, CHARLES
To: EAGLE PHARMACEUTICALS, INC.
Reel/Frame 046751/0019 →
Assignment of Assignor's Interest Dec 11, 2018
From: HEPNER, ADRIAN
To: EAGLE PHARMACEUTICALS, INC.
Reel/Frame 047740/0751 →
Assignment of Assignor's Interest Jan 10, 2020
From: EAGLE PHARMACEUTICALS, INC.
To: EAGLE RESEARCH LABS LIMITED
Reel/Frame 051478/0716 →
Security Interest Jan 22, 2020
From: EAGLE RESEARCH LABS LIMITED
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 051580/0604 →
Assignment of Assignor's Interest Mar 4, 2020
From: HEPNER, ADRIAN
To: EAGLE PHARMACEUTICALS, INC.
Reel/Frame 052012/0317 →
Assignment of Assignor's Interest Mar 4, 2020
From: HEPNER, ADRIAN
To: EAGLE PHARMACEUTICALS, INC.
Reel/Frame 052012/0271 →
Assignment of Assignor's Interest Jun 18, 2020
From: HEPNER, ADRIAN
To: EAGLE PHARMACEUTICALS, INC.
Reel/Frame 052979/0513 →
Assignment of Assignor's Interest Jun 18, 2020
From: HEPNER, ADRIAN
To: EAGLE PHARMACEUTICALS, INC.
Reel/Frame 052979/0075 →
Assignment of Assignor's Interest Jun 18, 2020
From: HEPNER, ADRIAN
To: EAGLE PHARMACEUTICALS, INC.
Reel/Frame 052979/0342 →
Assignment of Assignor's Interest Jun 18, 2020
From: HEPNER, ADRIAN
To: EAGLE PHARMACEUTICALS, INC.
Reel/Frame 052979/0711 →
Assignment of Assignor's Interest Aug 12, 2020
From: HEPNER, ADRIAN
To: EAGLE PHARMACEUTICALS, INC.
Reel/Frame 053469/0120 →
Assignment of Assignor's Interest Aug 12, 2020
From: HEPNER, ADRIAN
To: EAGLE PHARMACEUTICALS, INC.
Reel/Frame 053469/0247 →
Assignment of Assignor's Interest Aug 12, 2020
From: HEPNER, ADRIAN
To: EAGLE PHARMACEUTICALS, INC.
Reel/Frame 053468/0702 →
Assignment of Assignor's Interest Aug 12, 2020
From: HEPNER, ADRIAN
To: EAGLE PHARMACEUTICALS, INC.
Reel/Frame 053468/0611 →
Assignment of Assignor's Interest Nov 3, 2020
From: WESCOTT, CHARLES; COGHLAN, JILL
To: EAGLE PHARMACEUTICALS, INC.
Reel/Frame 054252/0627 →
Assignment of Assignor's Interest Oct 6, 2022
From: HEPNER, ADRIAN
To: EAGLE PHARMACEUTICALS, INC.
Reel/Frame 061334/0274 →
Assignment of Assignor's Interest Oct 6, 2022
From: HEPNER, ADRIAN
To: EAGLE PHARMACEUTICALS, INC.
Reel/Frame 061333/0643 →
Assignment of Assignor's Interest Oct 6, 2022
From: HEPNER, ADRIAN
To: EAGLE PHARMACEUTICALS, INC.
Reel/Frame 061333/0704 →
Assignment of Assignor's Interest Oct 6, 2022
From: HEPNER, ADRIAN
To: EAGLE PHARMACEUTICALS, INC.
Reel/Frame 061334/0239 →